Cargando…

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling

Esophageal cancer is one of the leading malignancies worldwide, while around sixty percent of newly diagnosed cases are in China. In recent years, genome-wide sequencing studies and cancer biology studies show that Hippo signaling functions a critical role in esophageal squamous cell carcinoma (ESCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Aijia, Wang, Weilong, Chen, Zhijun, Pang, Dan, Zhou, Xiaofeng, Lu, Kui, Hou, Jinghan, Wang, Sujie, Gao, Can, Lv, Benjie, Yan, Ziyi, Chen, Zhen, Zhu, Jian, Wang, Lidong, Zhuang, Ting, Li, Xiumin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939053/ https://www.ncbi.nlm.nih.gov/pubmed/31884247 http://dx.doi.org/10.1016/j.neo.2019.12.001

Ejemplares similares

Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2
por: Zhou, Xiaofeng, et al.
Publicado: (2020)

RACO‐1 modulates Hippo signalling in oesophageal squamous cell carcinoma
por: Pang, Dan, et al.
Publicado: (2020)

RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1
por: Yu, Na, et al.
Publicado: (2018)

SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation
por: Zhuang, Ting, et al.
Publicado: (2017)

SHARPIN Facilitates p53 Degradation in Breast Cancer Cells()()
por: Yang, Huijie, et al.
Publicado: (2017)

Advances in the Structural and Physiological Functions of SHARPIN
por: Yu, Beiming, et al.
Publicado: (2022)

SHARPIN is a key regulator of immune and inflammatory responses
por: Wang, Zhe, et al.
Publicado: (2012)

Aberrant expression and high-frequency mutations of SHARPIN in nonmelanoma skin cancer
por: Zheng, Yan, et al.
Publicado: (2019)

Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk
por: De Melo, Jason, et al.
Publicado: (2015)

Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR/Cas9 system
por: Miao, Jinxin, et al.
Publicado: (2022)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
por: Ma, Lijuan, et al.
Publicado: (2023)

Crystallization of SHARPIN using an automated two-dimensional grid screen for optimization
por: Stieglitz, Benjamin, et al.
Publicado: (2012)

Loss of Function of the Mouse Sharpin Gene Results in Peyer’s Patch Regression
por: Seymour, Rosemarie, et al.
Publicado: (2013)

Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression
por: Tanaka, Y, et al.
Publicado: (2016)

Serine 165 phosphorylation of SHARPIN regulates the activation of NF-κB
por: Thys, An, et al.
Publicado: (2020)

Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway
por: Li, Lin, et al.
Publicado: (2023)

SHARPIN Negatively Associates with TRAF2-Mediated NFκB Activation
por: Liang, Yanhua
Publicado: (2011)

Mutually Exclusive Roles of SHARPIN in Integrin Inactivation and NF-κB Signaling
por: De Franceschi, Nicola, et al.
Publicado: (2015)

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice
por: Rickard, James A, et al.
Publicado: (2014)

Sharpin prevents skin inflammation by inhibiting TNFR1-induced keratinocyte apoptosis
por: Kumari, Snehlata, et al.
Publicado: (2014)

Distinct role of IL-1β in instigating disease in Sharpin(cpdm) mice
por: Gurung, Prajwal, et al.
Publicado: (2016)

Keratinocyte-specific deletion of SHARPIN induces atopic dermatitis-like inflammation in mice
por: Sundberg, John P., et al.
Publicado: (2020)

A missense variant in SHARPIN mediates Alzheimer’s disease-specific brain damages
por: Park, Jun Young, et al.
Publicado: (2021)

Sharpin suppresses β1-integrin activation by complexing with the β1 tail and kindlin-1
por: Gao, Juan, et al.
Publicado: (2019)

PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail()
por: Zhai, Shicong, et al.
Publicado: (2017)

A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease
por: Asanomi, Yuya, et al.
Publicado: (2021)

SHARPIN Is Essential for Cytokine Production, NF-κB Signaling, and Induction of Th1 Differentiation by Dendritic Cells
por: Wang, Zhe, et al.
Publicado: (2012)

Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma
por: Wang, An, et al.
Publicado: (2023)

Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
por: Gao, Yanping, et al.
Publicado: (2017)

Development and Validation of the Predictive Model for Esophageal Squamous Cell Carcinoma Differentiation Degree
por: Wang, Yanfeng, et al.
Publicado: (2020)

Survival Risk Prediction of Esophageal Squamous Cell Carcinoma Based on BES-LSSVM
por: Wang, Yanfeng, et al.
Publicado: (2022)

CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
por: Xin, Huixian, et al.
Publicado: (2022)

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2017)

Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice
por: Peuhu, Emilia, et al.
Publicado: (2017)

Imaging genomics discovery of a new risk variant for Alzheimer's disease in the postsynaptic SHARPIN gene
por: Soheili‐Nezhad, Sourena, et al.
Publicado: (2020)

KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma
por: Sun, Xiaozheng, et al.
Publicado: (2020)

A novel SHARPIN-PRMT5-H3R2me1 axis is essential for lung cancer cell invasion
por: Fu, Tingxiong, et al.
Publicado: (2017)

Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
por: Yang, Boli, et al.
Publicado: (2021)

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma
por: Chen, Qiuyu, et al.
Publicado: (2023)

Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
por: Mai, Zihang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98pi7p3og5uokdiosg4gs6c9f1